ID
29110
Descripción
Ropinirole Case Report Form GSK RRL100013 GSK Study ID: 100013 Clinical Study ID: RRL100013 A 12-Week, Double-Blind, Placebo-Controlled, Twice-Daily Dosing Study to Assess the Efficacy and Safety of Ropinirole in Patients Suffering from Restless Legs Syndrome (RLS) Requiring Extended Treatment Coverage
Palabras clave
Versiones (4)
- 22/2/18 22/2/18 -
- 24/2/18 24/2/18 -
- 25/2/18 25/2/18 -
- 17/9/21 17/9/21 -
Titular de derechos de autor
gsk
Subido en
25 de febrero de 2018
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY-NC 3.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Ropinirole Case Report Form GSK RRL100013
Subject diary
Descripción
Subject Instructions
Descripción
Bring this diary and any unused study medication with you to your next clinic visit Enter the information in the diary every day as required Print neatly and legibly Use ink, preferably black, to complete the information in the diary If you make a mistake: Draw a single line through the incorrect entry and write the correct data nearby Do not "write over" or erase an incorrect entry Do not use correction materials, such as correction fluid or tape, on this diary Page 2 FINAL - 24 SEP 04 If you have questions or concerns, contact the study contact person listed on the front of the diary
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C3890583
- UMLS CUI [1,2]
- C0205197
- UMLS CUI [1,3]
- C0034394
Descripción
Patient global improvement scale instrucitons
Tipo de datos
text
Alias
- UMLS CUI [1]
- C3639888
Descripción
You will take 2 doses of study medication every day. You should generally take your first dose 1 hour prior to when your RLS symptoms usually start. Your second dose should be taken at bedtime and at least 3 hours after the first dose. You should try to take your second dose within 6 hours of the first dose, as longer time frames between doses (e.g., 8 hours or more) may lead to the reoccurrence of RLS symptoms.
Tipo de datos
text
Descripción
Dosing information
Alias
- UMLS CUI-1
- C0678766
Descripción
Dosage given:___________ Tablet x ___________ mg
Tipo de datos
text
Alias
- UMLS CUI [1]
- C0178602
Descripción
Date and time of dosing
Tipo de datos
datetime
Alias
- UMLS CUI [1,1]
- C0013227
- UMLS CUI [1,2]
- C0178602
- UMLS CUI [1,3]
- C0011008
- UMLS CUI [1,4]
- C0040223
Descripción
dose administered by
Tipo de datos
text
Alias
- UMLS CUI [1]
- C2348343
Descripción
Dose checked and witnessed by
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C0682356
- UMLS CUI [1,2]
- C1283174
- UMLS CUI [1,3]
- C0178602
Descripción
Comments
Tipo de datos
text
Alias
- UMLS CUI [1]
- C0947611
Descripción
Patient rated scale
Alias
- UMLS CUI-1
- C0681889
- UMLS CUI-2
- C1578483
Descripción
If the patient is eligible to continue in the study please continue the assessments for this visit as stated below: Remove the appropriate scales from the Patient Reported Outcomes Questionnaire Book and ask the patient to complete them in the following order: • RLS Quality of Life Questionnaire • SF36 Health Status Survey • Medical Outcome Study Sleep Scale • Work Productivity and Activity Impairment Questionnaire
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C0034394
- UMLS CUI [1,2]
- C0034380
- UMLS CUI [1,3]
- C0035258
Descripción
If the patient is eligible to continue in the study please continue the assessments for this visit as stated below: Remove the appropriate scales from the Patient Reported Outcomes Questionnaire Book and ask the patient to complete them in the following order: • RLS Quality of Life Questionnaire • SF36 Health Status Survey • Medical Outcome Study Sleep Scale • Work Productivity and Activity Impairment Questionnaire
Tipo de datos
text
Alias
- UMLS CUI [1]
- C3640521
Descripción
If the patient is eligible to continue in the study please continue the assessments for this visit as stated below: Remove the appropriate scales from the Patient Reported Outcomes Questionnaire Book and ask the patient to complete them in the following order: • RLS Quality of Life Questionnaire • SF36 Health Status Survey • Medical Outcome Study Sleep Scale • Work Productivity and Activity Impairment Questionnaire
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C0349674
- UMLS CUI [1,2]
- C0037313
Descripción
If the patient is eligible to continue in the study please continue the assessments for this visit as stated below: Remove the appropriate scales from the Patient Reported Outcomes Questionnaire Book and ask the patient to complete them in the following order: • RLS Quality of Life Questionnaire • SF36 Health Status Survey • Medical Outcome Study Sleep Scale • Work Productivity and Activity Impairment Questionnaire
Tipo de datos
text
Alias
- UMLS CUI [1]
- C3639722
Descripción
DOSING DETAILS
Alias
- UMLS CUI-1
- C0678766
Descripción
You will take 2 doses of study medication every day. You should generally take your first dose 1 hour prior to when your RLS symptoms usually start. Your second dose should be taken at bedtime and at least 3 hours after the first dose. You should try to take your second dose within 6 hours of the first dose, as longer time frames between doses (e.g., 8 hours or more) may lead to the reoccurrence of RLS symptoms
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C1442085
- UMLS CUI [1,2]
- C0678766
Descripción
Dosage given:___________ Tablet x ___________ mg
Tipo de datos
text
Alias
- UMLS CUI [1]
- C0178602
Descripción
Date and time of dosing
Tipo de datos
datetime
Alias
- UMLS CUI [1,1]
- C0013227
- UMLS CUI [1,2]
- C0178602
- UMLS CUI [1,3]
- C0011008
- UMLS CUI [1,4]
- C0040223
Descripción
dose administered by
Tipo de datos
text
Alias
- UMLS CUI [1]
- C2348343
Descripción
Dose checked and witnessed by
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C0682356
- UMLS CUI [1,2]
- C1283174
- UMLS CUI [1,3]
- C0178602
Descripción
Comments
Tipo de datos
text
Alias
- UMLS CUI [1]
- C0947611
Descripción
Actigraphy Information
Alias
- UMLS CUI-1
- C1171301
Descripción
(to be completed by study coordinator prior to giving diary to patient e.g. Monday, Tuesday)
Tipo de datos
date
Unidades de medida
- Day Month Year
Alias
- UMLS CUI [1,1]
- C0677547
- UMLS CUI [1,2]
- C0240526
- UMLS CUI [1,3]
- C0442592
Descripción
Was the device with the "Right" label worn on Right leg Actigraphy Information
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C1171301
- UMLS CUI [1,2]
- C0230442
Descripción
Was the device with the "Left" label worn on Left leg Actigraphy Information
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C1171301
- UMLS CUI [1,2]
- C0230443
Descripción
AM or PM (circle one)
Tipo de datos
time
Alias
- UMLS CUI [1]
- C4289366
Descripción
____ AM or PM (circle one)
Tipo de datos
time
Alias
- UMLS CUI [1,1]
- C0040223
- UMLS CUI [1,2]
- C1170730
Similar models
Subject diary
C0040223 (UMLS CUI [1,2])
C0035258 (UMLS CUI [1,3])
C0332189 (UMLS CUI [1,4])
C0035258 (UMLS CUI [1,2])
C0332189 (UMLS CUI [1,3])
C0001288 (UMLS CUI [1,2])
C0035258 (UMLS CUI [1,3])
C1457887 (UMLS CUI [1,2])
C0035258 (UMLS CUI [1,3])
C0013227 (UMLS CUI [2])
C1457887 (UMLS CUI [1,2])
C0035258 (UMLS CUI [1,3])
C0013227 (UMLS CUI [2])
C0392760 (UMLS CUI [1,2])
C0035258 (UMLS CUI [1,3])
C0037317 (UMLS CUI [1,2])
C0035258 (UMLS CUI [1,3])
C0205197 (UMLS CUI [1,2])
C0034394 (UMLS CUI [1,3])
C0178602 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
C0040223 (UMLS CUI [1,4])
C1283174 (UMLS CUI [1,2])
C0178602 (UMLS CUI [1,3])
C0034380 (UMLS CUI [1,2])
C0035258 (UMLS CUI [1,3])
C0037313 (UMLS CUI [1,2])
C0678766 (UMLS CUI [1,2])
C0178602 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
C0040223 (UMLS CUI [1,4])
C1283174 (UMLS CUI [1,2])
C0178602 (UMLS CUI [1,3])
C0240526 (UMLS CUI [1,2])
C0442592 (UMLS CUI [1,3])
C0230442 (UMLS CUI [1,2])
C0230443 (UMLS CUI [1,2])
C1170730 (UMLS CUI [1,2])